SCHEMBL30974263

SCHEMBL30974263

COc1ccc(-n2c(Br)nc3c(N)ncnc32)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 11/20 0.47
ADORA1 P30542 11/20 0.47
ADORA2B P29275 10/20 0.47
ADORA3 P0DMS8 5/20 0.47
TP53 P04637 1/20 0.44
HSP90B1 P14625 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
HSP90AA1 P07900 3/20 0.43
HSP90AB1 P08238 3/20 0.43
ERBB2 P04626 3/20 0.43
PI4KA P42356 1/20 0.41
PI4K2B Q8TCG2 1/20 0.41
PI4K2A Q9BTU6 1/20 0.41
PI4KB Q9UBF8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27422698 1.00 ADORA2A (0.47) ADORA2AADORA1ADORA2BADORA3TP53
SCHEMBL27422748 0.81 CYP3A4 (0.44) TP53MEN1KMT2ANPC1RAB9A
SCHEMBL27422663 0.77 PI4KA (0.64) ADORA2AADORA1MEN1KMT2ANPC1
SCHEMBL6355337 0.77 ADORA2A (0.50) ADORA2AADORA1ADORA2BADORA3PI4KA
SCHEMBL27422633 0.67 CYP3A4 (0.44) TP53MEN1KMT2A
SCHEMBL11862452 0.65 PI4KB (0.69) ADORA2AADORA1ADORA2BPI4KAPI4K2B
SCHEMBL1755068 0.65 ADORA2A (1.00) ADORA2AADORA1ADORA2BADORA3PI4KA
SCHEMBL29439771 0.65 ADORA2A (1.00) ADORA2AADORA1ADORA2BADORA3PI4KA
SCHEMBL8832637 0.65 ADORA2A (1.00) ADORA2AADORA1ADORA2BADORA3PI4KA
SCHEMBL10379475 0.64 ADORA2A (0.68) ADORA2AADORA1ADORA2BADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024129780-A1 BENZIMIDAZOLE DERIVATIVES AS GPX4 INHIBITORS SONATA THERAPEUTICS, INC. (US) 2024-06-20 WO disclosed